1. Електронний репозитарій ДВНЗ "УжНУ"

Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 11-20 of 96 (Search time: 0.002 seconds).
Item hits:
Issue DateTitleAuthor(s)
2013Resultsof a phase III, randomized, double-blind, placebocontrolledtrialofpegfilgrastim (PEG) inpatients (pts) receivingfirst-line FOLFOX or FOLFIRI andbevacizumab (B) forcolorectalcancer (CRC)Готько, Євген Степанович; Tamas Pinter; Esteban Abella; Alvydas Cesas; Adina Croitoru; Jochen Decaestecker; Peter Gibbs; Jacek Jassem; Galina Petrova Kurteva; Jan Novotny; Seamus O'Reilly; Tomas Salek; May F. Mo
2006-10Exercise training improves cardiac perfomance in diabetes: in vivo demonstration with quantitative cine-MRI analysisLoganathan, Rajprasad; Bilgen, Mehmet; Al-Hafez, Baraa; Zhero, Svyatoslav; Alenezy, Mohammed; Smirnova, Irina
2014HORMONOTHERAPY IN PATIENTS WITH BILATERAL BREAST CANCERГотько, Євген Степанович; D.Y. Tsyhyka; S.V. Zhero; D.V. Prygara; N.Y. Pogorelova; O.I. Tsyhyka; V.Y. Ihnatko; O.T. Devinyak
2002Хирургическое лечение рака молочной железы у мужчинГотько, Євген Степанович; Летягин, В. П.
2016-10-20Maintenance erlotinib versus erlotinib at disease progression inpatients with advanced non-small-cell lung cancer who have notprogressed following platinum-based chemotherapy (IUNO study)Saulius Cicènas; Sarayut Lucien Geater; Petar Petrov; Yevgeniy Hotko; Gregory Hooper; Fan Xia; Nadejda Mudie; Yi-Long Wu
2014-02Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation statusShikha Gaur; Linling Chen; Vincent Ann; Wei-Chen Lin; Yafan Wang; Vincent HS Chang; Yevgeniy Hotko; Her-Shuyong Shia; Nan Yong Hsu; Yun Yen
2007РАК ГРУДНОЇ ЗАЛОЗИ У У ЧОЛОВІКІВ: ВПЛИВ КАТЕГОРІЇ Т НА П ПРОГНОЗ ЗАХВОРЮВАННЯГотько, Євген Степанович; Сочка, А. В.
2013A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the PAVES StudyTamás Pintera; Zandra Klippel; Alvydas Cesas; Adina Croitoru; Jochen Decaestecker; Peter Gibbs; Yevhen Hotko; Jacek Jassem; Galina Kurteva; Jan Novotny; Seamus O’Reilly; Tomas Salek; Maureen Reiner; Phuong Khanh Morrow; Mi Rim Choi; Sadie Whittaker; Charles Blanke
2014HORMONOTHERAPY IN PATIENTS WITH BILATERAL BREAST CANCERY.S. Hotko; D.Y. Tsyhyka; S.V. Zhero; D.V. Prygara; N.Y. Pogorelova; O.I. Tsyhyka; V.Y. Ihnatko; O.T. Devinyak
2009-03Etude de phase III (20050181) de l’association panitumumab + 5-fluorouracile, acide folinique, irinotecan (Folfiri) versus Folfiri seul en seconde ligne de traitement des cancers colorectaux métastasés. Analyse poolée de toxicitéM. Ducreux; G. Wilson; A. Cervantès; T. André; Y. Hotko; F. Lordick; S. Collins; M. Shing; T. Price; M. Peeters

Discover